376 related articles for article (PubMed ID: 17951630)
1. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.
Deng YZ; Chen PP; Wang Y; Yin D; Koeffler HP; Li B; Tong XJ; Xie D
J Biol Chem; 2007 Dec; 282(50):36571-81. PubMed ID: 17951630
[TBL] [Abstract][Full Text] [Related]
2. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
[TBL] [Abstract][Full Text] [Related]
3. Krüppel-like factor 9 was down-regulated in esophageal squamous cell carcinoma and negatively regulated beta-catenin/TCF signaling.
Qiao F; Yao F; Chen L; Lu C; Ni Y; Fang W; Jin H
Mol Carcinog; 2016 Mar; 55(3):280-91. PubMed ID: 25641762
[TBL] [Abstract][Full Text] [Related]
4. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
5. The novel target of esophageal squamous cell carcinoma: lncRNA GASL1 regulates cell migration, invasion and cell cycle stagnation by inactivating the Wnt3a/β-catenin signaling.
Ren Y; Guo T; Xu J; Liu Y; Huang J
Pathol Res Pract; 2021 Jan; 217():153289. PubMed ID: 33248356
[TBL] [Abstract][Full Text] [Related]
6. Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.
Yang TW; Gao YH; Ma SY; Wu Q; Li ZF
World J Gastroenterol; 2017 May; 23(17):3066-3076. PubMed ID: 28533663
[TBL] [Abstract][Full Text] [Related]
7. RAP1B, a DVL2 binding protein, activates Wnt/beta-catenin signaling in esophageal squamous cell carcinoma.
Jia Z; Yang Y; Dengyan Z; Chunyang Z; Donglei L; Kai W; Song Z
Gene; 2017 May; 611():15-20. PubMed ID: 28119087
[TBL] [Abstract][Full Text] [Related]
8. Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin.
Huang BL; Brugger SM; Lyons KM
J Biol Chem; 2010 Sep; 285(36):27702-12. PubMed ID: 20571031
[TBL] [Abstract][Full Text] [Related]
9. p63-Mediated activation of the β-catenin/c-Myc signaling pathway stimulates esophageal squamous carcinoma cell invasion and metastasis.
Lee KB; Ye S; Park MH; Park BH; Lee JS; Kim SM
Cancer Lett; 2014 Oct; 353(1):124-32. PubMed ID: 25045846
[TBL] [Abstract][Full Text] [Related]
10. beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma.
Yan S; Zhou C; Zhang W; Zhang G; Zhao X; Yang S; Wang Y; Lu N; Zhu H; Xu N
Cancer Lett; 2008 Nov; 271(1):85-97. PubMed ID: 18602747
[TBL] [Abstract][Full Text] [Related]
11. Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma.
Kim MS; Chang X; LeBron C; Nagpal JK; Lee J; Huang Y; Yamashita K; Trink B; Ratovitski EA; Sidransky D
PLoS One; 2010 Feb; 5(2):e9003. PubMed ID: 20140245
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
13. β-Catenin-TCF/LEF signaling promotes steady-state and emergency granulopoiesis via G-CSF receptor upregulation.
Danek P; Kardosova M; Janeckova L; Karkoulia E; Vanickova K; Fabisik M; Lozano-Asencio C; Benoukraf T; Tirado-Magallanes R; Zhou Q; Burocziova M; Rahmatova S; Pytlik R; Brdicka T; Tenen DG; Korinek V; Alberich-Jorda M
Blood; 2020 Nov; 136(22):2574-2587. PubMed ID: 32822472
[TBL] [Abstract][Full Text] [Related]
14. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
[TBL] [Abstract][Full Text] [Related]
15. Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells.
Vangamudi B; Zhu S; Soutto M; Belkhiri A; El-Rifai W
Mol Cancer; 2011 Mar; 10():32. PubMed ID: 21447180
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway.
Wang Y; Zhou X; Zhu H; Liu S; Zhou C; Zhang G; Xue L; Lu N; Quan L; Bai J; Zhan Q; Xu N
Oncogene; 2005 Oct; 24(44):6637-45. PubMed ID: 16007168
[TBL] [Abstract][Full Text] [Related]
17. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
18. Frequent accumulation of nuclear E-cadherin and alterations in the Wnt signaling pathway in esophageal squamous cell carcinomas.
Salahshor S; Naidoo R; Serra S; Shih W; Tsao MS; Chetty R; Woodgett JR
Mod Pathol; 2008 Mar; 21(3):271-81. PubMed ID: 18084253
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.
Bu F; Liu X; Li J; Chen S; Tong X; Ma C; Mao H; Pan F; Li X; Chen B; Xu L; Li E; Kou G; Han J; Guo S; Zhao J; Guo Y
Oncotarget; 2015 Feb; 6(4):2120-33. PubMed ID: 25544767
[TBL] [Abstract][Full Text] [Related]
20. Down-regulated desmocollin-2 promotes cell aggressiveness through redistributing adherens junctions and activating beta-catenin signalling in oesophageal squamous cell carcinoma.
Fang WK; Liao LD; Li LY; Xie YM; Xu XE; Zhao WJ; Wu JY; Zhu MX; Wu ZY; Du ZP; Wu BL; Xie D; Guo MZ; Xu LY; Li EM
J Pathol; 2013 Oct; 231(2):257-70. PubMed ID: 23836524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
